Loading
הדסית ביו-ש is a listed company. Its insiders report their share dealings to TASE (ISA). Between 18 October 2025 and 18 October 2026, 7 insiders published 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
No insider has bought הדסית ביו-ש shares on the open market in the past twelve months.
Compared with its exchange (530 companies, median 13 filings), a count of 8 filings is below the norm.
Every figure here comes from the filings published by TASE (ISA) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
8 of 8 declarations
Hadasit Bio-Holdings is a company listed on the XTAE market, specializing in the biotechnology sector. It focuses on developing innovative solutions in the healthcare field.
Insider filings
Over the last 90 days, 3 filings published between 4 August and 7 October 2026: no open-market purchase or sale filed by an insider. 3 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 13 October 2026 (UTC)